Advanced search
Publication Cover
Journal of Asthma Volume 58, 2021 - Issue 4
Submit an article Journal homepage
640
Views
8
CrossRef citations to date
0
Altmetric
Pediatric Asthma

Incidence of supraventricular tachycardia after inhaled short-acting beta agonist treatment in children

Stephanie Woodwarda Department of Anesthesiology, University of North Carolina School of Medicine, Chapel Hill, NC, USA
, MD,
Michael Mundorffb Primary Children's Hospital, Salt Lake City, UT, USA
, MBA, MHSA,
Cindy Wengc Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA
, MS,
David G. Gamboad Department of Pediatrics Division of Pediatric Cardiology, Advocate Children’s Hospital, Oak Lawn, IL, USA
, MD &
Michael D. Johnsone Department of Pediatrics Division of Pediatric Emergency Medicine, University of Utah School of Medicine, Salt Lake City, UT, USACorrespondence[email protected]
, MD, MS
Pages 471-480 | Received 09 Aug 2019, Accepted 23 Dec 2019, Published online: 06 Jan 2020

References

  • Roemer M. Health care expenditures for the five most common children’s conditions, 2008: estimates for U.S. Civilian Noninstitutionalized Children, Ages 0–17; Agency for Healthcare Research and Quality; 2011.
  • National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart Lung and Blood Institue, National Institutes of Health, U.S. Department of Health and Human Services; 2007.
  • Sills MR, Ginde AA, Clark S, Camargo CA. Multicenter analysis of quality indicators for children treated in the emergency department for asthma. Pediatrics. 2012;129(2):e325–32. doi:10.1542/peds.2010-3302.
  • Camargo CA, Spooner C, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database Syst Rev. 2011;4:CD001115.
  • Bozzola E, Bozzola M, Barberi S, Cutrera R, Villani A. Safety and potential side effects of beta 2-agonists: a still debated question. Int J Pediatr Child Health. 2013;1(1):4–10. doi:10.12974/2311-8687.2013.01.01.2.
  • Lewis J, Arora G, Tudorascu DL, Hickey RW, Saladino RA, Manole MD. Acute management of refractory and unstable pediatric supraventricular tachycardia. J Pediatr. 2016:95–98.
  • Cook P, Scarfone RJ, Cook RT. Adenosine in the termination of albuterol-induced supraventricular tachycardia. Ann Emerg Med. 1994;24(2):316–319. doi:10.1016/S0196-0644(94)70146-6.
  • Keller KA, Bhisitkul DM. Supraventricular tachycardia: a complication of nebulized albuterol. Pediatr Emerg Care. 1995;11(2):98–99. doi:10.1097/00006565-199504000-00010.
  • Duane M, Chandran L, Morelli P. Recurrent supraventricular tachycardia as a complication of nebulized albuterol treatment. Clin Pediatr (Phila)). 2000;39(11):673–677. doi:10.1177/000992280003901109.
  • Trachsel D, Newth CJL, Hammer J. Adenosine for salbutamol-induced supraventricular tachycardia. Intensive Care Med. 2007;33(9):1676–1676. doi:10.1007/s00134-007-0673-4.
  • Hilal-Dandan R, Brunton LL. Pulmonary pharmacology In: Goodman and Gilman’s manual of pharmacology and therapeutics, 2e. New York (NY): McGraw-Hill Education; 2016.
  • Del Río-Navarro B, Gazca-Aguilar A, Quibrera Matienzo JA, Rodríguez Galván Y, Sienra-Monge JJ. Metabolic and electrocardiographic effects of albuterol in pediatric asthmatic patients treated in an emergency room setting. Allergol Immunopathol (Madr)). 2015;27(1):18–23. doi:10.1157/13057765.
  • Yamamoto LG, Wiebe RA, Rosen LM, Ringwood JW, Uechi CM, Miller NC, Beardsly ES, Toshi AS, Sugimoto SP, MacPherson KA, et al. Oxygen saturation changes during the pediatric emergency department treatment of wheezing. Am J Emerg Med. 1992;10(4):274–284. doi:10.1016/0735-6757(92)90002-F.
  • Moak JP. Supraventricular tachycardia in the neonate and infant. Prog Pediatr Cardiol. 2000;11(1):25–38. doi:10.1016/S1058-9813(00)00033-3.
  • Schlechte EA, Boramanand N, Funk M. Supraventricular tachycardia in the pediatric primary care setting: age-related presentation, diagnosis, and management. J Pediatr Heal Care. 2008;22(5):289–299. doi:10.1016/j.pedhc.2007.08.013.
  • Kelly A, Kennedy A, John BM, Duane B, Lemanowicz J, Little J. A comparison of heart rate changes associated with levalbuterol and racemic albuterol in pediatric cardiology patients. Ann Pharmacother. 2013;47(5):644–650. doi:10.1345/aph.1S003.
  • Habashy D, Lam LT, Browne GJ. The administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey. Eur J Emerg Med. 2003;10(3):219–224. doi:10.1097/00063110-200309000-00012.
  • Bratton SL, Newth CJL, Zuppa AF, Moler FW, Meert KL, Berg RA, Berger J, Wessel D, Pollack M, Harrison R, et al. Critical care for pediatric asthma: wide care variability and challenges for study. Pediatr Crit Care Med. 2012;13(4):407–414. doi:10.1097/PCC.0b013e318238b428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.